Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis

Autor: Hannes Uchtenhagen, Anca I. Catrina, Sara Turcinov, William W. Kwok, TH Ramwadhdoebe, Genadiy Kozhukh, Aase Haj Hensvold, Anatoly Dubnovitsky, Karine Chemin, Lisa G. M. van Baarsen, Vivianne Malmström, Adnane Achour, Lars Rönnblom, Christina Gerstner
Přispěvatelé: Graduate School, 01 Internal and external specialisms, AII - Inflammatory diseases, AII - Amsterdam institute for Infection and Immunity, Clinical Immunology and Rheumatology
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Adult
CD4-Positive T-Lymphocytes
Male
lcsh:Immunologic diseases. Allergy
Autoreactive CD4+ T lymphocytes
Immunology
Epitopes
T-Lymphocyte

Flow cytometry
Arthritis
Rheumatoid

03 medical and health sciences
0302 clinical medicine
Antigen
Autoimmune disease
medicine
Humans
Vimentin
Pyrophosphatases
Aged
030203 arthritis & rheumatology
Extracellular Matrix Proteins
medicine.diagnostic_test
business.industry
Histocompatibility Antigens Class II
Citrullination
Fibrinogen
Immunology in the medical area
Autoreactive CD4+T lymphocytes
Middle Aged
medicine.disease
Flow Cytometry
Multi-MHC class II tetramer assay
3. Good health
030104 developmental biology
Lymphatic system
Rheumatoid arthritis
Immunologi inom det medicinska området
Citrulline
Female
business
lcsh:RC581-607
Ex vivo
Blood drawing
Research Article
Zdroj: BMC Immunology, Vol 21, Iss 1, Pp 1-14 (2020)
BMC Immunology
BMC immunology, 21(1):27. BioMed Central
ISSN: 1471-2172
Popis: Background HLA class II tetramers can be used for ex vivo enumeration and phenotypic characterisation of antigen-specific CD4+ T cells. They are increasingly applied in settings like allergy, vaccination and autoimmune diseases. Rheumatoid arthritis (RA) is a chronic autoimmune disorder for which many autoantigens have been described. Results Using multi-parameter flow cytometry, we developed a multi-HLA class II tetramer approach to simultaneously study several antigen specificities in RA patient samples. We focused on previously described citrullinated HLA-DRB1*04:01-restricted T cell epitopes from α-enolase, fibrinogen-β, vimentin as well as cartilage intermediate layer protein (CILP). First, we examined inter-assay variability and the sensitivity of the assay in peripheral blood from healthy donors (n = 7). Next, we confirmed the robustness and sensitivity in a cohort of RA patients with repeat blood draws (n = 14). We then applied our method in two different settings. We assessed lymphoid tissue from seropositive arthralgia (n = 5) and early RA patients (n = 5) and could demonstrate autoreactive T cells in individuals at risk of developing RA. Lastly, we studied peripheral blood from early RA patients (n = 10) and found that the group of patients achieving minimum disease activity (DAS28 Conclusions Our study demonstrates the development of a sensitive tetramer panel allowing simultaneous characterisation of antigen-specific T cells in ex vivo patient samples including RA ‘at risk’ subjects. This multi-tetramer approach can be useful for longitudinal immune-monitoring in any disease with known HLA-restriction element and several candidate antigens.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje